ContractClinical Study Agreement • October 12th, 2021
Contract Type FiledOctober 12th, 2021CLINICAL STUDY AGREEMENT ZMLUVA O KLINICKOM SKÚŠANÍ AbbVie s.r.o., Karadžičova 10, 821 08 Bratislava, Slovak Republic, RN: 46640231, RN for tax: 2023529057, RN for VAT: SK2023529057, Legal Representative: Branislav Trutz, M.D., Company is registered in Trade Register of District Court Bratislava I. Part Sro, insertion no. 81375/B, date of registration 11.05.2012 (hereinafter referred to as "AbbVie") is entering into agreement with Fakultná nemocnica s poliklinikou F.D. Roosevelta Banská Bystrica, Nám. L. Svobodu 1, 975 17 Banská Bystrica, Slovak Republic, RN: 00165 549, RN for tax: 2021095670, RN for VAT: SK2021095670, represented by Ing. Miriam Lapuníková, MBA, Manager, established by Decision of Ministry of Health of the Slovak Republic No:1842/90-A/II-I on 18th of December 1990 (hereinafter referred to as the “Institution”) to conduct a clinical study (hereinafter referred to as the “Study”) in relation to Risankizumab and Ustekinumab (individually and collectively, the “Study Produ